Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 4.3.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)09961Ventolin (sir 1x150 ml (fľ.skl.jantár.))26.1.2022O
 4.3.2022GlaxoSmithKline Trading Services Limited (GAG-IRL-3)3798AZENTEL 400 mg (tbl 1x400 mg (blis.PVDC/PVC/Al))12.1.2022O
 4.3.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)13971Flixotide 50 Inhaler N (sus inh 1x120 dávok (nád.tlak.Al))3.2.2022R
 4.3.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)13975Flixotide 250 Inhaler N (sus inh 1x120 dávok (nád.tlak.Al))3.2.2022R
 4.3.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)42280Lacipil 6 mg (tbl flm 28x6 mg (blis.PVC/Al))2.2.2022R
 4.3.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)47314AVAMYS 27,5 mikrogramov/vstrek, nosová suspenzná aerodisperzia (aer nau 1x120 dávok/3300 µg (fľ.skl.jantár.))17.11.2021R
 4.3.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)94814Ventolin (sol neb 1x20 ml/100 mg (liek.skl.))2.12.2021R
 4.3.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)5994CBenlysta 200 mg injekčný roztok naplnený v injekčnom pere (sol ira 4x1 ml/200 mg (striek.inj.skl. v napl.pere))1.1.2022R
 4.3.2022Pharmaand GmbH (PNQ)20237Pegasys 180 mikrogramov injekčný roztok v naplnenej injekčnej striekačke (sol inj 1x0,5 ml (striek.inj.skl.napl.+inj.ihla))3.3.2022O
 3.3.2022UNIMED PHARMA, spol. s r.o. (XUN-1)33187UNICLOPHEN 0,1 % (int opo 1x10 ml (fľa. PE))4.3.2022O
 3.3.2022Bayer, spol. s r.o. (BAY-SK-2)31893Iberogast (sol por 1x20 ml (fľ.skl.hnedá))4.3.2022R
 3.3.2022KRKA, d.d., Novo mesto (KRK-2)0663DValtricom 5 mg/160 mg/12,5 mg filmom obalené tablety (tbl flm 30x5 mg/160 mg/12,5 mg (blis.OPA/Al/PVC/Al))7.3.2022O
 3.3.2022KRKA, d.d., Novo mesto (KRK-2)2220CDutrys 0,5 mg (cps mol 90x0,5 mg (blis.PVC/PE/PVDC/Al))28.3.2022R
 3.3.2022KRKA, d.d., Novo mesto (KRK-2)2579DDutasteride/Tamsulosin Krka 0,5 mg/0,4 mg tvrdé kapsuly (cps dur 90x0,5 mg/0,4 mg (fľ.HDPE))28.3.2022R
 3.3.2022KRKA, d.d., Novo mesto (KRK-2)38631Alventa 75 mg (cps pld 60x75 mg (blis.Al/PVC/PVDC))11.4.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)